Idebenone Research Blog
Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy
Idebenone (900 mg/day) significantly improves visual acuity in LHON patients at 3-6 months. Idebenone was shown…
Idebenone in Leber’s Hereditary Optic Neuropathy: A Review of Therapeutic Benefits
Idebenone (Raxone) is the only approved disease-specific therapy for LHON, restoring mitochondrial function and improving vision…
Idebenone Mitigates Gene Expression Changes After Traumatic Brain Injury: Focus on Ephrin-A and Dopamine Pathways
Idebenone TBI treatment in mice boosts early microglial genes while mitigating ephrin-A and dopamine signaling changes,…
Therapeutic Benefit of Idebenone in Leber Hereditary Optic Neuropathy: A Systematic Review and Meta-Analysis
Meta-analysis of 5 studies (375 patients) shows idebenone improves visual acuity in LHON by a mean…
Therapeutic Benefit of Idebenone in Leber Hereditary Optic Neuropathy: Insights from the LEROS Trial
LEROS trial confirms idebenone (900 mg/day) provides long-term vision benefits in Leber hereditary optic neuropathy (LHON)…
Idebenone for Neurodegenerative Diseases
Idebenone shows promise for Alzheimer’s, Friedreich’s ataxia, Parkinson’s, and Huntington’s by protecting mitochondrial function.